Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and evaluation of new quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity
Heba S. A. Elzahabi, Mohamed S. Nafie, Dina A. Osman, et al.
European Journal of Medicinal Chemistry (2021) Vol. 222, pp. 113609-113609
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 299-299
Open Access | Times Cited: 133
Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies
Mohamed M. Khalifa, Ahmed A. Al‐Karmalawy, Eslam B. Elkaeed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 37, Iss. 1, pp. 299-314
Open Access | Times Cited: 59
Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: In Vitro, in Vivo, molecular docking, molecular dynamics, and SAR studies
Mohamed M. Hammouda, Ayman Abo Elmaaty, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105995-105995
Closed Access | Times Cited: 38
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 35
Design, Synthesis, and Molecular Modeling Studies of a Novel Benzimidazole as an Aromatase Inhibitor
Ulviye Acar Çevik, İsmail Çeli̇k, Jaime Mella, et al.
ACS Omega (2022) Vol. 7, Iss. 18, pp. 16152-16163
Open Access | Times Cited: 28
Towards dual function of autophagy in breast cancer: A potent regulator of tumor progression and therapy response
Mehrdad Hashemi, Mahshid Deldar Abad Paskeh, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114546-114546
Open Access | Times Cited: 19
Design and synthesis of novel rigid dibenzo[ b,f ]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators
Mohammed Farrag El‐Behairy, Walaa Hamada Abd‐Allah, Mohamed M. Khalifa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 15
Nitrogen-fused Heterocycles: Empowering Anticancer Drug Discovery
Tanya Biswas, Ravi Kumar Mittal, Vikram Sharma, et al.
Medicinal Chemistry (2024) Vol. 20, Iss. 4, pp. 369-384
Closed Access | Times Cited: 6
Structure-based design of new anticancer N3-Substituted quinazolin-4-ones as type I ATP-competitive inhibitors targeting the deep hydrophobic pocket of EGFR
Ragaa Y El-Mahdy, Noha Galal, Rahma Lotfy, et al.
Computers in Biology and Medicine (2025) Vol. 186, pp. 109640-109640
Closed Access
Design and Synthesis of New Quinazolinone Derivatives Conjugated with Chalcone or Pyridazine Moieties: Anticancer Activities and Apoptotic Induction
Dina S. M. Elazab, Dina I. A. Othman, Khalid B. Selim, et al.
Polycyclic aromatic compounds (2025), pp. 1-24
Closed Access
New proapoptotic chemotherapeutic agents based on the quinolone-3-carboxamide scaffold acting by VEGFR-2 inhibition
Zeinab S. El-Fakharany, Yassin M. Nissan, Nada K. Sedky, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Synthesis, Characterization, and Cytotoxicity of New Spirooxindoles Engrafted Furan Structural Motif as a Potential Anticancer Agent
Mezna Saleh Altowyan, Saied M. Soliman, Matti Haukka, et al.
ACS Omega (2022) Vol. 7, Iss. 40, pp. 35743-35754
Open Access | Times Cited: 21
Acetic Acid Mediated for One-Pot Synthesis of Novel Pyrazolyl s-Triazine Derivatives for the Targeted Therapy of Triple-Negative Breast Tumor Cells (MDA-MB-231) via EGFR/PI3K/AKT/mTOR Signaling Cascades
Ihab Shawish, Assem Barakat, Ali Aldalbahi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1558-1558
Open Access | Times Cited: 19
Design and synthesis of new bis(1,2,4-triazolo[3,4-b][1,3,4]thiadiazines) and bis((quinoxalin-2-yl)phenoxy)alkanes as anti-breast cancer agents through dual PARP-1 and EGFR targets inhibition
Fatma M. Thabet, Kamal M. Dawood, Eman A. Ragab, et al.
RSC Advances (2022) Vol. 12, Iss. 36, pp. 23644-23660
Open Access | Times Cited: 18
Synthesis, DNA-binding, molecular docking, and cytotoxic activity of a new 4-amino-N-(5-selenocyanatothiazol-2-yl) benzenesulfonamide
Zeid Osama Owidah, Rayan M. Alansari, Moustafa A. Gouda, et al.
Journal of Molecular Structure (2023) Vol. 1286, pp. 135608-135608
Closed Access | Times Cited: 11
An Updated Overview on the Synthesis and Anticancer Evaluation of Quinazoline Derivatives
Jasneet Kaur, Sukhmeet Kaur, Amit Ȧnand, et al.
ChemistrySelect (2023) Vol. 8, Iss. 30
Open Access | Times Cited: 10
Design and synthesis of quinazolin-4-one derivatives as potential anticancer agents and investigation of their interaction with RecQ helicases
Hanan S. Haggag, Shaimaa M. Aboukhatwa, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107086-107086
Open Access | Times Cited: 3
In Vitro and In Vivo Studies of Anti-Lung Cancer Activity of Artemesia judaica L. Crude Extract Combined with LC-MS/MS Metabolic Profiling, Docking Simulation and HPLC-DAD Quantification
Marwa S. Goda, Mohamed S. Nafie, Basma Awad, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 17-17
Open Access | Times Cited: 21
Unveiling the Therapeutic Potential of Quinazolinone Derivatives in Cancer Treatment: A Comprehensive Exploration
Jasneet Kaur, Sukhmeet Kaur, Muskan, et al.
ChemistrySelect (2024) Vol. 9, Iss. 32
Closed Access | Times Cited: 2
Synthesis of New Bioactive Indolyl-1,2,4-Triazole Hybrids As Dual Inhibitors for EGFR/PARP-1 Targeting Breast and Liver Cancer Cells
Mohamed F. Youssef, Mohamed S. Nafie, Eid E. Salama, et al.
ACS Omega (2022) Vol. 7, Iss. 49, pp. 45665-45677
Open Access | Times Cited: 13
The Antiproliferative and Apoptotic Effects of a Novel Quinazoline Carrying Substituted-Sulfonamides: In Vitro and Molecular Docking Study
Ali S. Alqahtani, Mostafa M. Ghorab, Fahd A. Nasr, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 981-981
Open Access | Times Cited: 11
Silver Nanoparticles Formulation of Flower Head’s Polyphenols of Cynara scolymus L.: A Promising Candidate against Prostate (PC-3) Cancer Cell Line through Apoptosis Activation
Amgad I. M. Khedr, Marwa S. Goda, Abdelaziz F. S. Farrag, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6304-6304
Open Access | Times Cited: 11
Current progress in the targeted therapy of breast cancer: Structure–activity correlation and docking studies (2015–2021)
Shivanshu Pandey, Sitanshu Mondal, Kumari Kajal, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 8
Closed Access | Times Cited: 6
Design, synthesis, molecular modelling and antitumor evaluation of S -glucosylated rhodanines through topo II inhibition and DNA intercalation
Ahmed I. Khodair, Fatimah Mohammed Alzahrani, Mohamed K. Awad, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 5
N‐allyl quinoxaline derivative exhibited potent and selective cytotoxicity through EGFR/VEGFR‐mediated apoptosis: In vitro and in vivo studies
Mohamed S. Nafie, Mohab A. Ali, Magdy M. Youssef
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 4
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top